You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MyD88

Showing 1 - 25 of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • MYD88 Gene Mutation
  • Boston, Massachusetts
  • +1 more
Apr 1, 2022

Non-GCB/ABC DLBCL, With and Without MyD88 and/or CD79B Mutations Trial in Cleveland, Toledo (Mivavotinib)

Recruiting
  • Non-GCB/ABC Diffuse Large B-Cell Lymphoma
  • With and Without MyD88 and/or CD79B Mutations
  • Evanston, Illinois
  • +6 more
Dec 12, 2022

Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, DLBCL Trial in United States (KT-413)

Recruiting
  • Non Hodgkin Lymphoma
  • +3 more
  • Washington, District of Columbia
  • +5 more
Nov 29, 2022

ASO and Beta-hemolytic Group A Streptococcus Infections in

Unknown status
  • Attention Deficit-Hyperactivity Disorder
  • Antistreptolysin O Test
  • +3 more
  • Orbassano, Torino, Italy
    AOU San Luigi Gonzaga di Orbassano
Mar 23, 2020

Diffuse Large B-cell Lymphoma Trial in Switzerland (Acalabrutinib)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Bergamo, Italy
  • +16 more
Jan 17, 2023

Waldenström's Macroglobulinemia Trial in Worldwide (BGB-3111, Ibrutinib)

Completed
  • Waldenström's Macroglobulinemia
  • Phoenix, Arizona
  • +79 more
Jul 6, 2022

Waldenstrom Macroglobulinemia Trial (Zanubrutinib)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • (no location specified)
Nov 28, 2022

Waldenstrom Macroglobulinemia Trial in Austria, Germany, Greece (Carfilzomib + Ibrutinib, Ibrutinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Salzburg, Austria
  • +16 more
Mar 11, 2022

Innate on the Inflammatory Response to Endotoxin

Recruiting
  • Asthma
  • +4 more
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Dec 7, 2022

    Waldenstrom Macroglobulinemia Trial (Venetoclax; Rituximab, DRC)

    Not yet recruiting
    • Waldenstrom Macroglobulinemia
    • Venetoclax; Rituximab
    • DRC
    • (no location specified)
    Nov 4, 2022

    Diffuse Large B Cell Lymphoma Trial in Shenyang (Zanubrutinib, Rituximab, Cyclophosphamide)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • Shenyang, Liaoning, China
      Xing Xiaojing
    Jun 1, 2023

    Waldenstrom's Disease, Prognostic Index Trial in France

    Not yet recruiting
    • Waldenstrom's Disease
    • Prognostic Index
      • Amiens, France
      • +14 more
      Jun 12, 2023

      Waldenstrom Macroglobulinemia Trial in Japan (Ibrutinib, Rituximab)

      Active, not recruiting
      Has Results
      • Waldenstrom Macroglobulinemia
      • Chiba, Japan
      • +8 more
      Jan 27, 2023

      Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

      Not yet recruiting
      • Waldenstrom Macroglobulinemia
      • B-Cell Lymphoproliferative Disorder
      • Boston, Massachusetts
      • +2 more
      Feb 18, 2023

      Waldenstrom Macroglobulinemia Trial in Boston (Loncastuximab Tesirine, Dexamethasone)

      Recruiting
      • Waldenstrom Macroglobulinemia
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Mar 1, 2022

      MRD and Clonal Evolution in Waldenström's Macroglobulinemia and

      Active, not recruiting
      • Waldenstrom Macroglobulinemia
      • MRD and clonal evolution
      • Milano, MI, Italy
      • +13 more
      Nov 2, 2022

      Chronic Lymphocytic Leukemia (CLL) Trial

      Completed
      • Chronic Lymphocytic Leukemia (CLL)
        • (no location specified)
        Apr 5, 2022

        Diffuse Large B Cell Lymphoma Trial in Shanghai (zanubrutinib)

        Recruiting
        • Diffuse Large B Cell Lymphoma
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Mar 13, 2022

        Urinary Tract Infections, Chronic Urinary Tract Infection, Recurrent Urinary Tract Infection Trial in Worldwide (Uromune)

        Available
        • Urinary Tract Infections
        • +4 more
        • Uromune
        • Brussels, Belgium
        • +14 more
        Mar 28, 2022

        MicroRNAs and Cytokines in Peri-Implantitis Tissue

        Active, not recruiting
        • Peri-implantitis
          • Baghdad, Iraq
            Munir
          Mar 14, 2023

          Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy Trial in United States (Emavusertib, ibrutinib)

          Recruiting
          • Relapsed Hematologic Malignancy
          • Refractory Hematologic Malignancy
          • Phoenix, Arizona
          • +10 more
          Feb 1, 2023

          Waldenstrom's Disease Trial in Rouen (Determination of mutation)

          Unknown status
          • Waldenstrom's Disease
          • Determination of mutation
          • Rouen, France
            Centre Henri Becquerel
          Jul 29, 2020

          Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

          Not yet recruiting
          • Monoclonal Gammopathy of Uncertain Significance
          • Zanubrutinib Oral Product
          • Utrecht, Netherlands
            University Medical Center Utrecht
          Jul 6, 2023

          Waldenstrom Macroglobulinemia Trial in Canada (Acalabrutinib, Bendamustine, Rituximab)

          Recruiting
          • Waldenstrom Macroglobulinemia
          • Calgary, Alberta, Canada
          • +8 more
          Nov 9, 2022

          Genetic Variants and Susceptibility to Diseases of Prematurity

          Recruiting
          • Chronic Lung Disease
          • gene variations
          • Milwaukee, Wisconsin
            Children's Hospital of Wisconsin
          Jan 25, 2022